Tests included 36 parameters listed
Explore the tests in Women Cancer Screening Advanced by category.
Cancer Markers 4
CA 15.3 CA 19.9 CA-125 CARCINO EMBRYONIC ANTIGEN (CEA)
Complete Hemogram 28
BASOPHILS BASOPHILS - ABSOLUTE COUNT EOSINOPHILS EOSINOPHILS - ABSOLUTE COUNT HEMATOCRIT(PCV) HEMOGLOBIN IMMATURE GRANULOCYTE PERCENTAGE(IG%) IMMATURE GRANULOCYTES(IG) LYMPHOCYTE LYMPHOCYTES - ABSOLUTE COUNT MEAN CORP.HEMO.CONC(MCHC) MEAN CORPUSCULAR HEMOGLOBIN(MCH) MEAN CORPUSCULAR VOLUME(MCV) MEAN PLATELET VOLUME(MPV) MONOCYTES MONOCYTES - ABSOLUTE COUNT NEUTROPHILS NEUTROPHILS - ABSOLUTE COUNT NUCLEATED RED BLOOD CELLS NUCLEATED RED BLOOD CELLS % PLATELET COUNT PLATELET DISTRIBUTION WIDTH(PDW) PLATELET TO LARGE CELL RATIO(PLCR) PLATELETCRIT(PCT) RED CELL DISTRIBUTION WIDTH (RDW-CV) RED CELL DISTRIBUTION WIDTH - SD(RDW-SD) TOTAL LEUCOCYTES COUNT (WBC) TOTAL RBC
Pregnancy 1
Pregnancy 1
Thyroid 2
CALCITONIN THYROGLOBULIN (TG)
Profile visual guide View larger ↗
Tap the guide to enlarge it and read every detail.
Pinch with two fingers to zoom. Swipe to explore, or use + and −.
Women’s Marker Panel Reference Guide
This fasting profile reports 36 listed blood-test results. It includes four selected tumour markers and a complete hemogram. AFP, beta-hCG, calcitonin and thyroglobulin are also included. These markers cannot screen for or diagnose cancer by themselves.
Why This Test Is Ordered
Reason Description
Know the exact profile scope CA-125 is included within selected tumour markers. CA 15.3, CA 19.9 and CEA are included. AFP and beta-hCG are also listed. Calcitonin and thyroglobulin complete the marker groups. Understand marker limitations Tumour markers are not reliable stand-alone screening tests. A normal marker result cannot exclude cancer. An elevated marker does not prove cancer. Noncancerous conditions can affect marker results. Plan appropriate follow-up A clinician considers symptoms and personal history. Family cancer history can change the evaluation plan. Imaging or tissue testing may be needed. Use prior reports only with matching laboratory context.
Symptoms And Who Should Test
Situation Description
People with clinician-directed questions Testing may follow a clinician’s specific concern. Bring referral details when they are available. Share personal and family cancer history. Mention previous surgery, imaging or treatment. People needing marker follow-up Serial results can be useful in selected situations. The clinician decides whether repeat testing is appropriate. Trends should use comparable reports where possible. Do not compare results without their reference intervals. People with new concerning symptoms Persistent bloating or pelvic pain needs clinical assessment. Unexplained vaginal bleeding needs timely medical advice. A new breast lump needs prompt examination. Blood markers should not delay symptom evaluation.
Preparation And Interpretation Notes
Topic Guidance
Prepare for collection Complete an overnight fast before sample collection. The package uses serum and EDTA blood samples. Confirm collection timing with the laboratory team. Follow any clinician-specific medicine instructions. Bring useful health information Carry earlier reports when they are available. List prescription medicines and supplements. Mention current pregnancy or recent pregnancy changes. Record symptoms, duration and relevant family history. Use results safely Do not treat a marker result as diagnosis. Do not delay recommended imaging or examinations. Discuss abnormal results with the ordering clinician. Seek urgent care for severe or worsening symptoms.
Frequently Asked Questions
Does this profile diagnose cancer?
No; diagnosis requires clinical assessment and may need imaging or tissue testing.
Can it screen average-risk women for cancer?
No; these markers are not reliable stand-alone screening tests.
Does a normal result rule out cancer?
No; normal tumour-marker results cannot rule out cancer.
Does a high result prove cancer?
No; noncancerous conditions can raise some tumour markers.
Which tumour markers are included?
CA-125, CA 15.3, CA 19.9 and CEA are included.
Does it include a complete blood count?
Yes; the profile includes a complete hemogram.
Does it include thyroid-related markers?
Yes; calcitonin and thyroglobulin are included.
Is fasting required?
Yes; complete an overnight fast before collection.
Should symptoms wait for these results?
No; persistent or concerning symptoms need prompt clinical assessment.
Can I book this profile in {city}?
Collection in {city} depends on your address and serviceability.
Who can review results in {city}?
A clinician in {city} can review results with your history.